Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. RXO
2. GOOGL
3. SYRE
4. MRVL
5. OPCH
6. AMD
7. BDX
8. PTC
9. CEG
10. POLA

Go back to Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

Tyme Technologies (TYME) Prices 40M Share Registered Direct Common Offering at $2.50/Sh

February 4, 2021 6:00 AM EST

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), today announced that it has entered into definitive agreements with several healthcare-focused institutional and other institutional investors for the sale of an aggregate of 40,000,000 shares of its common stock at a purchase price of $2.50 per share in a registered direct offering priced at-the-market under... More

Tyme Technologies (TYME) Climbs 110%

February 3, 2021 8:17 AM EST

Tyme Technologies (NASDAQ: TYME) Climbs 110%

Earlier Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections... More